0001104659-21-011783.txt : 20210203
0001104659-21-011783.hdr.sgml : 20210203
20210203202246
ACCESSION NUMBER: 0001104659-21-011783
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210201
FILED AS OF DATE: 20210203
DATE AS OF CHANGE: 20210203
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Chakravarthy Manu
CENTRAL INDEX KEY: 0001774648
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38901
FILM NUMBER: 21588328
MAIL ADDRESS:
STREET 1: C/O AXCELLA HEALTH INC.
STREET 2: 840 MEMORIAL DRIVE
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Axcella Health Inc.
CENTRAL INDEX KEY: 0001633070
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 840 MEMORIAL DRIVE
STREET 2: THIRD FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 617-868-0949
MAIL ADDRESS:
STREET 1: 840 MEMORIAL DRIVE
STREET 2: THIRD FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
FORMER COMPANY:
FORMER CONFORMED NAME: Pronutria Biosciences, Inc.
DATE OF NAME CHANGE: 20150206
4
1
tm215314-2_4seq1.xml
OWNERSHIP DOCUMENT
X0306
4
2021-02-01
0
0001633070
Axcella Health Inc.
AXLA
0001774648
Chakravarthy Manu
C/O AXCELLA HEALTH INC.
840 MEMORIAL DRIVE
CAMBRIDGE
MA
02139
0
1
0
0
SVP & Chief Medical Officer
Common Stock
2021-02-01
4
M
0
60000
A
60000
D
Common Stock
2021-02-01
4
S
0
18472
5.5019
D
41528
D
Restricted Stock Units
2021-02-01
4
M
0
60000
0
A
Common Stock
60000
60000
D
Each restricted stock unit represents a contingent right to receive one share of AXLA common stock.
Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs listed in Table II and does not represent a discretionary trade by the reporting person.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.38 to $5.68, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
The restricted stock units vested in full on February 1, 2021.
By: /s/ Manu Chakravarthy
2021-02-03